PACRGL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.161000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.530400E-02
Normal-vs-Stage2
6.747400E-01
Normal-vs-Stage3
3.638000E-01
Normal-vs-Stage4
3.306000E-01
Stage1-vs-Stage2
2.136200E-02
Stage1-vs-Stage3
1.968330E-02
Stage1-vs-Stage4
2.870200E-01
Stage2-vs-Stage3
1.143050E-01
Stage2-vs-Stage4
5.545600E-01
Stage3-vs-Stage4
9.676100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.202200E-01
Normal-vs-AfricanAmerican
6.128000E-01
Normal-vs-Asian
5.401400E-01
Caucasian-vs-AfricanAmerican
9.207400E-01
Caucasian-vs-Asian
9.118600E-01
AfricanAmerican-vs-Asian
8.556600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.255600E-01
Normal-vs-Female
6.095000E-01
Male-vs-Female
9.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.049000E-01
Normal-vs-Age(41-60Yrs)
4.201000E-01
Normal-vs-Age(61-80Yrs)
7.584600E-01
Normal-vs-Age(81-100Yrs)
5.577200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.560400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.384200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.542800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.662000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.518800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.467000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.356000E-01
Normal-vs-Daily Drinker
6.959000E-01
Normal-vs-Weekly Drinker
8.491600E-01
Normal-vs-Occasional Drinker
3.196800E-01
Normal-vs-Social Drinker
5.122000E-01
Non Drinker-vs-Daily Drinker
6.737800E-01
Non Drinker-vs-Weekly Drinker
9.883000E-01
Non Drinker-vs-Occasional Drinker
4.963800E-02
Non Drinker-vs-Social Drinker
2.635400E-01
Daily Drinker-vs-Weekly Drinker
7.502600E-01
Daily Drinker-vs-Occasional Drinker
1.394980E-01
Daily Drinker-vs-Social Drinker
3.559800E-01
Weekly Drinker-vs-Occasional Drinker
1.320970E-01
Weekly Drinker-vs-Social Drinker
3.216000E-01
Occasional Drinker-vs-Social Drinker
7.683400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.425000E-01
Normal-vs-Grade 2
7.990400E-01
Normal-vs-Grade 3
7.682400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.932800E-01
Grade 1-vs-Grade 3
7.110000E-01
Grade 1-vs-Grade 4
5.425000E-01
Grade 2-vs-Grade 3
5.317200E-01
Grade 2-vs-Grade 4
7.990400E-01
Grade 3-vs-Grade 4
7.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.588400E-01
Normal-vs-NonDiabetic
5.531200E-01
Diabetic-vs-NonDiabetic
1.828270E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.959000E-01
Normal-vs-NoPancreatitis
6.640400E-01
Pancreatitis-vs-NoPancreatitis
8.827400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.082600E-01
Normal-vs-N1
7.097600E-01
N0-vs-N1
1.295590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.313200E-01
Normal-vs-TP53-NonMutant
5.118000E-01
TP53-Mutant-vs-TP53-NonMutant
7.059400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
